Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches
Advanced Drug Delivery Reviews · 2024-07 · 210 · 115326
DOI: 10.1016/j.addr.2024.115326 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-07. Verfasst von Tanvi Karve und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. Hauptthemen laut MEDLINE: Administration, Cutaneous, Drug Delivery Systems, Delayed-Action Preparations. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eastern Virginia Medical School, University of Connecticut, USAID.
Abstract (Originalsprache)
Transdermal administration remains an active research and development area as an alternative route for long-acting drug delivery. It avoids major drawbacks of conventional oral (gastrointestinal side effects, low drug bioavailability, and need for multiple dosing) or parenteral routes (invasiveness, pain, and psychological stress and bio-hazardous waste generated from needles), thereby increasing patient appeal and compliance. This review focuses on the current state of long-acting transdermal drug delivery, including adhesive patches, microneedles, and molecularly imprinted polymeric systems. Each subsection describes an approach including key considerations in formulation development, design, and process parameters with schematics. An overview of commercially available conventional (adhesive) patches for long-acting drug delivery (longer than 24 h), the reservoir- and matrix-type systems under preclinical evaluation, as well as the advanced transdermal formulations, such as the core-shell, nanoformulations-incorporated and stimuli-responsive microneedles, and 3D-printed and molecularly imprinted polymers that are in development, is also provided. Finally, we elaborated on translational aspects, challenges in patch formulation development, and future directions for the clinical advancement of new long-acting transdermal products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
- CONRAD, Eastern Virginia Medical School, Norfolk, VA 23507, USA. Electronic address: vagrahari@conrad.org.
- CONRAD, Eastern Virginia Medical School, Norfolk, VA 23507, USA.
- Center for Drug Delivery Research, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. Electronic address: banga_ak@mercer.edu.
Förderung
- Eastern Virginia Medical School
- University of Connecticut
- USAID
- U.S. President’s Emergency Plan for AIDS Relief
Zitieren
APA
Karve, T., Dandekar, A., Agrahari, V., Melissa Peet, M., Banga, A. K., & Doncel, G. F. (2024). Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches. Advanced Drug Delivery Reviews, 210, 115326. https://doi.org/10.1016/j.addr.2024.115326
Vancouver
Karve T, Dandekar A, Agrahari V, Melissa Peet M, Banga AK, Doncel GF. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches. Advanced Drug Delivery Reviews. 2024;210:115326. doi:10.1016/j.addr.2024.115326
BibTeX
@article{Karve2024,
author = {Karve, Tanvi and Dandekar, Amruta and Agrahari, Vivek and Melissa Peet, M and Banga, Ajay K and Doncel, Gustavo F},
title = {Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {210},
pages = {115326},
doi = {10.1016/j.addr.2024.115326}
}
EUVIMED